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Introduction:  Many asthmatics complain of worsening respiratory symptoms during periods of stress. 
This study evaluated the relationship among asthma symptoms, lung physiology, inflammatory parameters 
and perceived cognitive stress and quality of life in healthy adult students. This relationship was assessed 
at two time points: a time of normal activity and at a time of cognitive stress during academic examinations. 
Methods: Subjects attended the University of Alberta Hospital for a screening visit, which included a 
clinical exam, spirometry, methacholine challenge, allergen skin tests to assess atopy status and Mini 
International Neuropsychiatric Interview (MINI).  Eligible subjects returned for a low stress visit (LSV) at 
least 14 days prior to an exam and a high stress visit (HSV) within 24 hours of an exam.  Spirometry, and 
methacholine challenge were performed during both LSV and HSV along with the collection of urine (tested 
for cortisol), and the administration of 4 questionnaires to assess perceived stress and quality of life.
Results:  Subjects showed no significant change in psychosocial or quality of life questionnaires between 
LSV and HSV.  No significant change was noted in lung function or urine cortisol. There was an unexpected 
high rate of pre-existing psychiatric comorbidities in this population (based on the MINI screen failure rate).
Conclusion:  We did not find a significant change in quality of life, psychosocial wellbeing or pulmonary 
function or inflammation, measured by urine cortisol, during a high stress period.  The high rate of 
comorbidities would be important to consider as part of evaluation used in clinical asthma studies in the future.
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Asthma is a chronic inflammatory disorder of the 
airways characterized by sudden or persistent 
symptoms of shortness of breath, chest tightness, 
wheezing, sputum production, and cough.  It is 
associated with variable airflow limitation and 
varying degrees of airway hyper-responsiveness 
to endogenous and exogenous stimuli (Becker 
et al., 2005; Global Initiative for Asthma, 2016). 
Asthma is the most common chronic disease 
of childhood and affects over 8% of Canadians 
over the age of twelve (Global Initiative for 
Asthma, 2016; Statistics Canada, 2017). 
Many factors affect disease activity and 
severity of symptoms, including exposure 
to allergens, upper and lower airway 
infections, air pollution, and psychological/
cognitive stress (Christensen et al., 2008). 
The association of asthma symptoms with stress 
has been recognized as early as the 12th century 
(Rosner, 1981); Sir William Osler similarly referred 
to asthma as “a neurotic affliction” (Osler, 1892). 
Stress was first described by Hans Selye as the 
common denominator of all the adaptive reactions 
in the body (Selye, 1970).  Stress can be viewed as a 
process that accentuates the airway inflammatory 
response to environmental triggers and, in doing 
so, increases the frequency, duration, and severity 
of asthma patients’ symptoms (Chen & Miller, 
2007). It is the maladaptive response to stress, 
which Selye named “distress”, that is considered 
to be detrimental for human homeostasis and 
for diseases such as asthma (Selye, 1970). 
Psychological morbidity has been linked to asthma 
mortality (Strunk et al., 1985; Sears et al., 1986) 
and underlying psychological distress (depression 
and anxiety) (Wright et al., 1998).  Depression 
and asthma have a bidirectional relationship, 
with depression increasing the chance of 
asthma exacerbations and asthma increasing 
the chance of depressive symptomatology (Lu 
et al., 2014; Trueba et al., 2016). Between 20-35% 
of asthmatics experience asthma exacerbations 
during periods of stress (Isenberg et al., 1992). 
The National Institutes of Health commissioned 
a workshop to promote a better understanding of 
this relationship (Busse et al., 1995); however, little 
has been done to evaluate the mechanism of these 
interactions (Smyth et al., 1999; Davis et al., 2002). 
Some asthmatics experience a reduction in lung 
function with stress; however, these results are not 
consistent (Lehrer et al., 1993). A survey of over 
3,000 adults in the United States showed increased 
prevalence of panic attacks in those with obstructive 
lung disease (Goodwin, & Pine, 2002).  Similarly, 
depression and anxiety are over-represented in 
children (Vila et al., 1999; Sundbom et al., 2016) 
and adults (Sundbom et al., 2016; Krommydas et 
al., 2004; Harrison, 1998) with asthma. Stress also 
has many forms: panic disorders and depression 
can lead to shortness of breath, which appears to 
be unresponsive to bronchodilators or traditional 
eosinophil based anti-inflammatory therapy (i.e. 
psychogenic dyspnea). Moreover, perceived stress 
depends on one’s beliefs and values, which can 
negatively affect the physiological reaction to 
stress through cortisol release (Lu et al., 2014; 
Trueba et al., 2016). Psychosocial stress may 
further affect environmental triggers to asthma 
leading to exacerbations and negative asthma 
outcomes (Dunton et al., 2016).  Increased 
psychological stress among asthmatics has 
been shown to worsen asthma control, increase 
medical service use and increased medication 
requirements (Sunbom et al., 2016). Such stress 
has also been found to worsen morbidity and 
demonstrate pulmonary physiological changes, 
requiring more medications and follow up to 
manage symptoms exacerbations and functioning 
(Lu et al., 2014; Dunton et al., 2016). There is 
evidence for alterations to the immune system 
with stress (Black, 2002; Sundbom et al., 2016), 
and demonstrated airway structure and function 
impairment with long-term stress (Rod et al., 2012).
Psychological stress can be due to conditions such 
as relationship issues, financial difficulties, work-
related stress, or cognitive stress such as during 
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examinations. The impact of a condition on a 
person involves assessment of symptoms, airway 
inflammation, and effect on day-to-day activities. 
The World Health Organization’s definition of health 
encompasses this view as “a state of complete 
physical, mental, and social well-being – not merely 
the absence of disease or infirmity” (World Health 
Organization, 2018).  Among those with asthma 
that have a comorbid psychiatric pathology, 
there is a reduced quality of life as measured 
by standardized testing (Sundbom et al., 2016). 
Assessment of airway inflammation is a more 
sensitive measure of disease control than 
symptoms and lung function alone, and a 
measurable inflammatory response is present in 
atopic asthmatics despite clinical remission (Van 
Den Toorn et al., 2001). Atopy is a genetic condition 
of increased immunological response with 
underlying medical conditions including allergic 
rhinitis (hay fever), asthma and atopic dermatitis 
(eczema) (American Academy of Allergy Asthma 
& Immunology, 2018). Recent work utilizing the 
model of allergen challenge in mild asthmatics 
has shown changes in serum inflammatory 
markers during periods of stress, and increased 
airway inflammation after allergen challenge 
during high stress periods (Liu et al., 2002). 
This pilot study attempted to assess the 
relationship between cognitive stress and 
asthma symptoms, physiology (airway narrowing 
and forced expiratory volume), urine cortisol a 
marker of inflammation, and quality of life with 
both general and disease specific validated 
instruments. We postulated that FEV1 and PC20 
would decrease with increased stress. We 
expected that physiologic changes and quality 
of life measures would correlate with increased 
cognitive stress.  The relationship between 
cognitive stress and asthma was assessed at 
two time points: a time of normal activity (low 
stress visit) and again at a time of cognitive 
stress during examinations (high stress visit). 
Assessment of the subjects’ perceived anxiety 
was done at both time points using validated tools. 
Study Design 
The study was approved by the Health Research 
Ethics Board at the University of Alberta, issue 
number 5240 (legacy file). A two-point crossover 
study design (random order) was used (Table 1). 
The study was advertised by posters and handbills 
throughout the University of Alberta.  No financial 
compensation was provided to the subjects as it was 
felt that this might skew the types of participants 
responding to this study (recruitment bias). 
Subjects were interviewed by telephone to 
determine whether they were eligible for the 
screening visit. University students (over age 18) 
who had a diagnosis of mild asthma, were clinically 
stable at baseline evaluation (as determined by 
an asthma specialist), and were hyper-responsive 
to methacholine challenge, a bronchoprovocative 
agent that stimulates airway narrowing, during 
the screening visit were included.  Patients using 
inhaled steroids were included if their steroid dose 
remained stable during the course of the study. 
Pregnant/lactating women, smokers, and those 
with a significant medical condition that was felt 
to interfere with the study were excluded.  Subjects 
with major psychiatric disorders (DSM-IV Axis 1 
disorders) were excluded from the sample on the 
basis of the Mini International Neuropsychiatric 
Interview (MINI) screen (Sheehan et al., 1998).
If a subject had an asthma exacerbation or 
an upper/lower airway infection at the time of 
any visit, the visit was delayed or rescheduled 
for at least four weeks following resolution 
of symptoms, to ensure recovery and stable 
clinical parameters related to the study.
  
Clinical and Laboratory Evaluation of the Subjects
Clinical review of cognitive stress and asthma 
symptoms was performed by an asthma specialist 
Methods





during all three visits (Table 1).  Subjects had their 
low stress visit (LSV) at least fourteen days prior 
to examinations, by following the protocol similar 
to crossover allergy studies (Bizikova, 2016). 
Their high stress visit (HSV) was scheduled 24 
hours prior to a scheduled exam to elicit a high 
stress experience without affecting academic 
performance of our participants and to minimize 
subject dropout.  Subjects also had a methacholine 
challenge, spirometry, and a sputum induction 
performed at screening, LSV, and HSV visits. 
Urine cortisol levels were measured from eight-
hour urine samples at both the LSV and HSV. 
Spirometry was performed using standards set 
by the American Thoracic Society (American 
Thoracic Society Statement, 1995) using a 
spirometer (Viasys Encore system). Spirometry 
was performed at baseline, after each dose of 
methacholine, and post-methacholine challenge 
using a calibrated rolling seal spirometer 
(Sensormedics 22). During spirometry, the patient 
breathes into and rapidly out of a calibrator 
(Johns et al., 2008). Methacholine challenge 
was performed using standardized techniques 
(American Thoracic Statement, 2000; Cockcroft, 
1985) to evaluate bronchial hyper-responsiveness 
at each visit.  Participants began the challenge by 
breathing in a low dose of methacholine followed 
by immediate assessment of the forced expiration 
measured over one second (FEV1) with spirometry 
afterwards (John et al., 2008). Doubling doses of 
Provocholine® stock (Methapharm) were given 
to determine the provocative dose causing a 20% 
fall in FEV1 from baseline (PC20). Low PC20 (PC20 
<16 mg/mL) indicates that bronchoconstriction 
is attained at lower doses of provocation and 
deemed a more reactive airway. In patients 
without asthma, PC20 is greater than 16 mg/mL. 
Allergen skin testing to characterize atopic 
status was performed at the time of screening 
using a standardized bank of allergens and 
appropriate positive and negative controls 
(Omega Laboratories). The allergens included 
pollen, mold, animal dander, and house dust 
mite extracts. Participants with positive allergen 
skin testing results were deemed atopic.
Tests/Questionnaires Screening Visit Low Stress Visit High Stress Visit
Clinical review/exam X X X






Sputum Induction X X X
MINI Screen X
Allergen Skin Testing X
Urine Cortisol (8 hrs) X X
Perceived Stress Scale X X
MASQ (Total) X X




AQLQ (Overall Scores) X X
Table 1: Study design 
Tests/questionnaires done at each visit are represented by an X.






At the LSV and HSV, subjects were administered 
four questionnaires by the research associate: 
general (EuroQol-5D), disease-specific Asthma 
Quality of Life Questionnaires (AQLQ), Mood and 
Anxiety Syndrome Questionnaire (MASQ), and 
Perceived Stress Scale (PSS).
The PSS is a validated tool, sensitive to 
examination stress and was used to quantify 
stress levels in participating individuals (Cohen 
et al., 1988; Chiu et al., 2003; Garg et al., 2001). 
The MASQ is a series of 77 questions divided into 
three subsections (general distress, symptoms 
specific to depression and symptoms specific to 
anxiety)(Watson et al., 1995a). The MASQ, which 
discriminates between depressive anhedonia, 
an inability to feel pleasure, and somatic anxiety 
(Watson et al., 1995a; Watson et al., 1995b), was 
used to rate symptoms in the week prior to each 
test.  The AQLQ is a disease-specific quality of 
life measure for asthma that has been validated 
(Juniper et al., 1999).  The AQLQ is a series of 32 
questions within four domains (symptoms, activity 
limitations, emotional function and environmental 
stimuli) which are assessed on a seven-point scale 
with 1 indicating severely impaired and 7 indicating 
not impaired at all (American Thoracic Society, 
2017). Mean scores are assessed per domain and 
overall for the AQLQ (American Thoracic Society, 
2017). Quality of life is important to evaluate in 
asthma, but does not always reflect disease 
severity. Reduced quality of life in the asthma 
population may be accounted for by a combination 
of many factors, including disease severity and 
stress. Conditions other than the disease under 
evaluation may contribute to reduced quality of 
life, so a separate tool to assess overall quality 
of life is required in conjunction with the above. 
The EQ-5D is a validated measure of general 
quality of life (EuroQol group, 1990) that has 
been used for assessing quality of life in various 
diseases, including asthma (Chen et al., 2007; 
McTaggert-Cown et al., 2008; Szende et al., 2009).
Statistical Analysis
Data are shown as mean values ± standard 
error of the mean (SEM). For methacholine 
challenge results the geometric mean is 
shown. Paired t-test was used for data analysis.
Results
Screening
Thirty-eight people were interviewed and twenty-
two were brought in for a screening visit.  The 
majority of subjects interviewed by telephone and 
who did not come for a screening visit declined 
to participate because of the time commitment 
or the lack of financial compensation. 
Of the twenty-two subjects that attended the 
screening visit (Table 2), eight (36.4%) failed the 
MINI screen for reasons of generalized or social 
anxiety disorder, depressive or manic episodes, 
and alcohol abuse (four subjects failed for more 
than one of these reasons).  Eighty percent of 
participants who completed the study were 
taking inhaled steroids at the time of the study. 
Two subjects did not have current asthma.  One 
subject was no longer a student so could not meet 
the criteria of exam stress.  Five subjects dropped 
out before completing the study due to the time 
commitment.  Five subjects completed the study.
  
Study Subjects
The demographics of the five subjects who 
completed the study are shown in Table 3 and 
the asthma and stress data from these subjects 
is summarized in.  Of these five subjects, three 
were females and two were males, four were 
atopic and one was non-atopic, as measured by 
allergen skin testing (Table 2).  The mean age 
was 28 years.  Four subjects were on low dose 
inhaled corticosteroids during the study period.
  





Biological sex Years Atopic Status Screen FEV1 % ref. Screen PC20 mg/mL
SUBJECTS WHO WITHDREW BEFORE COMPLETION OF STUDY
F 22 ND* 67 ND
M 20 ND 84 ND
F 23 + 104 0.302
F 41 - 92 5.64
F 21 + 100 1.69
Mean=25.4 Mean=89.40 Geometric  
Mean=1.42
SUBJECTS WHO DID NOT MEET INCLUSION CRITERIA
M 25 + 83 ND
M 21 + 79 2.71
M 26 + 92 >16
M 29 ND 99 >16
Mean=25.2 Mean=88.25 Geometric 
Mean=8.853
SUBJECTS WHO FAILED MINI SCREEN
F 18 - 120 5.12
M 41 ND ND ND
F 20 ND ND ND
F 26 ND 114 ND
F 28 + 105 0.067
M 22 + 99 ND
M 52 ND 104 ND
M 21 ND 87 ND
Mean=28.5 Mean=104.8 Geometric 
Mean=0.59
Age Gender Atopic 
Status
Reporting worsening 
of asthma with stress
Screen 
FEV% ref
Use of low dose In-
haled Corticosteroids
PC20 (Baseline)
39 F + no 119 None 7.87
19 M - no 121 Fluticasone 13.4
21 F + no 72 Fluticasone 0.34
37 F + yes 105 Beclomethasone 0.042
24 M + yes 99 Fluticasone 0.048
Table 2:  Baseline characteristics of in-person screened subjects that did not participate in the study 
ND=No data; F = female; M = male;  
FEV1 = the forced expiratory volume in one second as measured by spirometry
PC20 = the dosage of methacholine required to reduce FEV1 by 20%
Positive atopy status = positive allergen testing; 
Ŧ Geometric mean log base 10
Table 3:  Demographics of subjects who completed study
F = female; M = male 
FEV1 = the forced expiratory volume in one second as measured by spirometry
PC20 = dose of methacholine required to decrease FEV1 by 20%






Two of the five subjects had a history of stress-
related worsening of their asthma.  The geometric 
mean PC20 (at screening visit) for the group 
that completed the study was 0.5913 mg/mL.
Psychosocial Measures
Subjects who completed the study showed 
no significant change in the PSS between 
the LSV and HSV (p=0.5078). Similarly, no 
change was noted in total scores for the MASQ 
(p=0.3057). There was a trend towards increase 
in the General Distress subsection of this 
questionnaire (p=0.0795), although this also 
did not reach statistical significance (Table 4). 
Quality of Life Measures
No significant change was noted in the 
general quality of life questionnaire (EQ-
5D) evaluations or disease specific AQLQ 
(AQLQ Overall: p=0.6460, Symptoms: 
p=0.9331) between the LSV and HSV (Table 4).
Airway Physiology
No significant change was noted in lung function 
(FEV1 %) between LSV and HSV (p=0.5275) (Table 
4). The results of the methacholine challenge 
(PC20) also showed no significant difference 
(p=0.9813) in airway hyper-responsiveness 
between low and high stress visits (Figure 1).
Table 4:  Summary of data from subjects who completed study
Screening LSV HSV p-value (between 
LSV and HSV)€
FEV1 % ref   (n=5)ŧ 
(SEM)
103.2 (19.75)* 104.0 (15.65) 108.0 (14.46) 0.53
PC20 (n=5) Geomet-
ric mean ¶
0.5913 1.012 1.574 0.98
AQLQ (Overall 
Scores) (n=5)
Not applicable 6.366 (0.6063) 6.456 (0.2324) 0.65
EQ-5D Health Ques-
tionnaire (n=5)
Not applicable 8.50 (0.6042) 8.10 (0.8689) 0.27
Perceived Stress 
Scale (n=5)
Not applicable 26.60 (5.225) 31.40 (6.580) 0.26
MASQ (Total)  
(n=5)
Not applicable 92.60 (21.71) 97.0 (24.34) 0.31
MASQ (General 
Distress)  (n=5)
Not applicable 26.20 (5.805) 30.0 (7.906) 0.08
Urine Cortisol (total 
8 hours) (n=4)
Not applicable 120.3 (27.22) 73.25 (64.16) 0.20
FEV1 = the forced expiratory volume in one second as measured by spirometry
LSV = low stress visit; HSV = high stress visit
PC20 = dose of methacholine required to decrease FEV1 by 20%
* Data shown as: Mean (standard deviation)
¶ Geometric mean of methacholine challenge results (PC20) - log based 10
ŧ Number of subjects who completed test on each visit successfully
€ Calculated using paired t-tests






No significant difference was noted between 
the LSV and HSV in either concentrated (g/L) 
or total (μg) urinary cortisol levels when testing 
eight-hour urine samples received at each visit 
(p=0.3012 and p=0.2017 respectively)(Table 4).
Underlying psychiatric diagnoses (as per the 
DSM-IV, the current edition of the DSM at the 
time of recruitment) were prevalent in this 
“healthy asthma” population recruited for our 
study. The recruitment resulted in the exclusion 
of a large number of subjects (36%) - similar to 
numbers quoted in other studies (Harrison, 1998; 
Krommydas et al., 2004; Strunk et al., 2016).  In the 
subjects who completed the study, no significant 
physiological or inflammatory worsening of 
asthma was noted during the putative HSV. We 
did not notice any significant change in quality of 
life measures. The main limitation of the study, 
in addition to the small number of subjects, was 
that these individuals did not exhibit elevated 
stress levels during the examination period as 
assessed by the MASQ and PSS scales. This 
may have been in part related to the underlying 
use of inhaled corticosteroids (ICS). Current 
hypotheses focus on the role of eosinophils a 
type of white blood cell, as a mechanism targeted 
by inhaled corticosteroids, implicated in asthma 
and stress (Black, 2002; Chen et al., 2007). 
Since our subjects did not have increased stress 
levels during what we expected to be an HSV, it 
is difficult to draw any conclusions about the 
effects of stress on allergic airway inflammation. 
However, the limitations of the study outline 
the necessity of identifying psychosocial 
factors and appreciating the individual 
reactions to stress, which may have effects on 
physiological processes in allergic diseases. 
As psychiatric pathology is prevalent in the asthma 
population, it is important in future studies to 
screen prior, as it may be a confounding variable 
to the effect of stress on airway disease. Different 
scales may be important with specific research 
questions involving the relationship between 
stress and asthma; hence careful involvement 
with clinical professionals working with these 
patients is important to evaluate the relevance of 
psychiatric comorbidities in asthma.  Indeed, based 
on the high prevalence of psychiatric comorbidity, 
asthma specialists at the University of Alberta 
have started formal psychiatric comorbidity 
evaluation of clinical asthma patients in clinic.
As mentioned, because subjects did not seem 
“stressed” during the HSV, the individual stress 
phenotype, the type of stress assessed, and 
duration of stress (chronic, acute, situational) 
Figure 1: Methacholine Challenge 
Data points are geometric means with 95% 
confidence interval (log base 10) 
for the PC20 (dose of methacholine required 
to drop FEV1 by 20%) of the five subjects who 
completed the study.
LSV = Low Stress Visit 
HSV = High Stress Visit
Discussion





may have varied between subjects but may be 
more important as further studies are developed 
to look at this issue. Although our study is small, it 
underscores the importance of objective measures 
of stress, such as the inflammatory markers 
of stress, for studies on the effects of stress 
on asthma or other inflammatory conditions. 
We postulated that there would be decreases in 
FEV1 and PC20 associated with increased stress, 
with more notable changes in quality of life 
measures.  We also expected that physiologic 
changes and quality of life measures would 
correlate with increased cognitive stress, 
along with airway inflammation. Unfortunately, 
with no changes in stress levels, these 
hypothesis could not be rigorously tested. 
Out of the five patients participating in the 
study only two reported a history of worsening 
of respiratory symptoms during periods 
of stress. It is interesting that both these 
patients were atopic and had severe airway 
hyperreactivity (PC20 of 0.042 and 0.048 mg/
mL).  Severe airway hyper-responsiveness may 
predispose an individual to increased symptoms 
during a stressful period (Rod et al., 2012). 
The low sample size reflects study interruption, 
which could increase the likelihood of type 2 error, 
noting no significant difference when a difference 
exists (Kadam et al., 2016). The low study 
completion (n=5) related to the large number of 
inclusion and exclusion criteria and inflexibility in 
scheduling the HSV (within 24 hours of their exam). 
For future studies, incentivizing completion of 
follow-up appointments, sending reminder emails 
about upcoming appointments and making 
follow-up appointments less complex to reduce 
the time commitment may increase the subject 
pool (Ngune et al., 2012; Kadam et al., 2016). 
We do believe this information is still important 
to share given the implications for future study 
designs in asthma clinical trials. From this data 
and review of the literature, it is important to use 
an interdisciplinary approach to management of 
asthma including family physicians, allied health, 
psychiatry and pulmonary medicine. Identification 
of risk factors, medication management and 
adjustments by stress and regular follow-
up will promote improved functioning and 
quality of life among individuals with asthma. 
Studies on asthma should incorporate measures 
of psychiatric comorbidity to better elucidate 
factors related to loss of asthma control. 
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